Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma
Dominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Transplantation and Cellular Therapy
|
November 7, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy
Simone Dertschnig, Peter Gergely, Jürgen Finke, et al.
European Journal of Haematology
|
February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation
Udo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Ejhaem
|
September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells
Tim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.
Annals of Hematology
|
November 17, 2022
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
Jorge Garcia Borrega, Boris Böll, Matthias Kochanek, et al.
Blood Advances
|
July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple Myeloma
Tim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.
Blood Advances
|
June 13, 2022
Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study
Nico Gagelmann, Gerald Georg Wulf, Johannes Duell, et al.
Human Gene Therapy
|
August 30, 2017
Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use
Dominik Lock, Nadine Mockel-Tenbrinck, Katharina Drechsel, et al.
Microorganisms
|
August 27, 2021
Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
Veronica Di Cristanziano, Patrick Affeldt, Moritz Trappe, et al.
Frontiers in Oncology
|
October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
Ann-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Clinical Lymphoma, Myeloma & Leukemia
|
January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma
Dominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Transplantation and Cellular Therapy
|
November 7, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy
Simone Dertschnig, Peter Gergely, Jürgen Finke, et al.
European Journal of Haematology
|
February 24, 2015
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation
Udo Holtick, Jens-Markus Chemnitz, Alexander Shimabukuro-Vornhagen, et al.
Ejhaem
|
September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells
Tim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.
Annals of Hematology
|
November 17, 2022
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
Jorge Garcia Borrega, Boris Böll, Matthias Kochanek, et al.
Blood Advances
|
July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple Myeloma
Tim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.
Blood Advances
|
June 13, 2022
Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study
Nico Gagelmann, Gerald Georg Wulf, Johannes Duell, et al.
Human Gene Therapy
|
August 30, 2017
Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use
Dominik Lock, Nadine Mockel-Tenbrinck, Katharina Drechsel, et al.
Microorganisms
|
August 27, 2021
Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
Veronica Di Cristanziano, Patrick Affeldt, Moritz Trappe, et al.
Frontiers in Oncology
|
October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
Ann-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Page
of 10